Literature DB >> 23362816

Effect of inhaled dry powder mannitol on mucus and its clearance.

Evangelia Daviskas1, Bruce K Rubin.   

Abstract

Insufficient hydration at the airway surface can make mucus adherent and poorly cleared. Cough, the major mechanism of mucus clearance in disease, is ineffective when mucus is adhesive. Inhaled mannitol creates an osmotic drive for water to move into the airway lumen. The consequent increased hydration of the airway surface decreases the adherence of mucus to the epithelium, facilitates the coupling of mucus and cilia thereby increasing mucus clearance. Inhaled mannitol also promotes effective coughing and stimulates mucociliary clearance. The beneficial effect of mannitol on mucus and its clearance has been demonstrated in patients with asthma, bronchiectasis and cystic fibrosis. Inhaled dry powder mannitol (Bronchitol™) is promising to be an effective treatment for the clearance of retained airway secretions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23362816     DOI: 10.1586/ers.12.72

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  6 in total

Review 1.  Use of mucoactive agents in cystic fibrosis: A consensus survey of Italian specialists.

Authors:  Sonia Volpi; Vincenzo Carnovale; Carla Colombo; Valeria Raia; Francesco Blasi; Giovanni Pappagallo
Journal:  Health Sci Rep       Date:  2022-06-06

Review 2.  Secretion properties, clearance, and therapy in airway disease.

Authors:  Bruce K Rubin
Journal:  Transl Respir Med       Date:  2014-03-10

Review 3.  Airway Epithelial Cell Cilia and Obstructive Lung Disease.

Authors:  Asma Yaghi; Myrna B Dolovich
Journal:  Cells       Date:  2016-11-11       Impact factor: 6.600

Review 4.  Primary Ciliary Dyskinesia: An Update on Clinical Aspects, Genetics, Diagnosis, and Future Treatment Strategies.

Authors:  Virginia Mirra; Claudius Werner; Francesca Santamaria
Journal:  Front Pediatr       Date:  2017-06-09       Impact factor: 3.418

5.  Genetics, diagnosis, and future treatment strategies for primary ciliary dyskinesia.

Authors:  M Leigh Anne Daniels; Peadar G Noone
Journal:  Expert Opin Orphan Drugs       Date:  2014-11-29       Impact factor: 0.694

Review 6.  Optimising inhaled mannitol for cystic fibrosis in an adult population.

Authors:  Patrick A Flume; Moira L Aitken; Diana Bilton; Penny Agent; Brett Charlton; Emma Forster; Howard G Fox; Helge Hebestreit; John Kolbe; Jonathan B Zuckerman; Brenda M Button
Journal:  Breathe (Sheff)       Date:  2015-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.